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Background
Aggressive intravenous fluid replacement regimens are tradition-
ally employed with the intention of protecting patients from
perioperative decreases in renal blood flow. In contrast to these
regimens, Enhanced Recovery Pathways (ERPs) often employ in-
traoperative goal-directed fluid therapy and postoperative fluid
restriction with permissive oliguria. While ERPs have been
proven to reduce physiologic stress and improve outcomes in
general, their impact on postoperative renal function remains
unknown.
Methods
Patients undergoing major colorectal surgery within an ERP (2/
2010 to 3/2013) were compared with a matched-control group
undergoing surgery without an ERP (10/2004-10/2007) at a single
institution.
Multivariable regression models were employed to examine the
effect of ERPs on the change in postoperative creatinine and in-
cidence of acute kidney injury (based on the RIFLE criteria).
Results
A total of 1054 patients were included: 590 patients in the ERP group,
and 464 patients in the control group. Patient age, gender and race
were similar between groups. The ERP group more often had signifi-
cant comorbidities (62 % ASA ≥3 vs. 40 % ASA ≥3, p < 0.001), non-
benign indications for surgery (81 % vs. 74 %, p = 0.045), and more
extensive surgery (48 % vs. 12 % proctectomy, p < 0.001) compared
to control. Unadjusted median increase in postoperative creatinine
was slightly higher in ERP vs. control (0.1 vs. 0 mg/dL, respectively).
After multivariable regression adjustment, postoperative change in
creatinine was similar in ERP vs. control (p = 0.25). Compared to con-
trol, ERP associated with similar rates of postoperative acute kidney© 2016 The Author(s). Open Access This artic
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zeinsufficiency (3.7 % ERP vs. 3.7 %) and acute Kidney failure (0.8 % vs.
0.9 %).
Conclusions
Implementation of an ERP in colorectal surgery is not associated
with a clinically significant increase in the level of perioperative
creatinine change or an increased incidence of postoperative
acute kidney injury. Further studies should be conducted to
address the risks and benefits of ERP in other surgical
populations.A2
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Enhanced recovery after surgery (ERAS) is standardized, coordi-
nated, interdisciplinary perioperative care plans that incorporate
evidence-based interventions to minimize surgical stress, improve
physiologic and functional recovery, reduce complications, and
thereby facilitate earlier discharge from the hospital. The benefits
of ERAS have been also demonstrated in patients undergoing uro-
logical, gynecological, upper gastrointestinal, hepatobiliary, car-
diac, and vascular surgery. ERAS programs can improve clinical
outcomes, also are associated with a reduction in costs as a result
of the reduction in LOS and morbidity. The cost effectiveness and
economic benefits of implementation of ERAS program had been
examined.
Methods
Literatures review was performed. The studies with cost saving
data were included in the review. The results were shown in
the table.
Conclusion
Economic data from multiple studies supported that ERAS can im-
prove healthcare quality with lower cost.le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
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Background/Introduction
Enhanced Recovery Pathways (ERP’s) focus on the delivery of bundles
of evidence-based care practices that expedite a patient’s recovery
and return to normal function. Central to recovery is establishing
early mobilization and enteral nutrition.
It is well recognized that there are barriers to successful implementa-
tion of ERP’s [1]. One of these includes successful dissemination of a
pathway and the goals of treatment to a multidisciplinary team. We
were interested to examine the opinions of a group of experts, when
defining those basic principles of eating, drinking and mobilizing
after surgery.
Methods
Individuals invited to an enhanced surgical recovery working group
meeting in Europe (n = 13) were contacted by email in December
2015 to anonymously complete an online questionnaire that probed
their literal understanding of the definitions of eating, drinking and
mobilizing after surgery.
All members of the working group had agreed to participate at
the meeting, with the intent that it was important to identify
variation, and ultimately establish a consensus, and in what
these definitions meant in clinical practice to different
individuals.
Results
All individuals contacted (n = 13) completed the questionnaire. There
was variation in defining each domain, (eating, drinking and mobiliz-
ing). For drinking, the greatest number to agree (53.8 %, n = 7/13)
described this feature as “return to baseline fluid intake”. 15.4 % (n =
2/13) qualified this definition as “sips of clear fluid”. For eating, again
there was wide variation in defining the term. “Light solid intake (such
as sandwich/fruit/yoghurt)” was the most cited response, by (53.8 %,
n = 7/13) respondents. The greatest variation in responses was seen
in defining mobilization after surgery. No consensus was reached,
with equal numbers (n = 2) defining this postoperative goal as either
“sitting out of bed”, “minimal steps”, “independent walking without as-
sistance” or “return to baseline function”.Conclusion
This small “snapshot” of experts’ views demonstrates an unmet need
to more clearly define the goals for patients after surgery.
Interestingly, there is significant variation amongst champions of en-
hanced recovery in defining those important terms of eating, drink-
ing and mobilizing after surgery. From this, we might infer that the
delivery of clear guidance to adopters of enhanced recovery prac-
tices may be compromised, with the effect of diluting the impact of
patient’s realizing these important goals.
In our institutions, we recommend explicitly defining these goals for
patients and healthcare professionals in both patient information
and published pathways. By effectively disseminating clear informa-
tion, we anticipate less ambiguity in the interpretation of ERP’s, lead-
ing to better understanding of the provenance of the pathway by all.
Moreover, we feel these important and agnostic indicators of recov-
ery should be at the very heart of the focused drive of ERP’s.
References
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Background/Introduction
In the past, administration of intraoperative fluid therapy was guided
by changes in blood pressure, heart rate, arterial waveform and cen-
tral venous pressure. However these methods of measurements are
neither sensitive nor specific. Now newer technologies are available
to optimize haemodynamic status such as the esophageal Doppler,
pulse pressure waveform analysis and changes in bioimpedance.
In the United Kingdom, many guidelines (GIFTASUP [1], NICE [2]) rec-
ommend the use of intraoperative fluid monitoring for surgical pa-
tients to achieve optimized perioperative fluid therapy. It forms an
important element of goal directed therapy to tailor an individual’s
fluid requirements to achieve central normovolaemia.
Methods
Two educational workshops were carried out for cardiac output (CO)
monitoring during a perioperative medicine meeting. Participants
were then asked 4 questions on their IOFM practices. A set of an-
swers was listed and an audience participation system using keypad
was used to sample the participants.
Results
The majority of participants (55 %, n = 40) would utilize CO monitor-
ing during major risk cases or major surgery cases to guide their intra
operative practice. Fifty five percent (n = 21) also stated they would
attempt to incorporate IOFM into their routine practice.
Among the participants (n = 26) who were not sure or unlikely to im-
plement IOFM, the main reason was due to participants not being
convinced with evidence for carrying out intraoperative monitoring
(38 %) followed by the lack of agreement among peers (20 %). Only
12 % blamed lack of funding from their hospital or lack of equip-
ment to carry out the practice. 22 % would adopt the practice if
more education were provided (Fig. 1).
Conclusion
We have shown from the small cohort sampled that there are only a
small proportion of anaesthetists that would not utilize CO
optimization for moderate to high-risk surgical cases. Most clinicians
therefore see the advantages of employing such practice. Education
seems to be an important driving factor for the uptake of IOFM
among the sampled cohort.
IOFM (and protocols) can lead to decreased variability of intraopera-
tive fluid practices. The ultimate aim is to avoid excessive fluid re-
striction or overload in surgical patients, which has been associated
with poorer outcomes [3].
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Background/Introduction
Perioperative medicine is the patient-centered, multidisciplinary and
integrated medical care of patients from the moment of contempla-
tion of surgery until full recovery. It builds on the Enhanced Recovery
approach to capitalize on five key opportunities: collaborative
decision-making, preoperative lifestyle modification, standardization
of perioperative care, achieving full postoperative recovery and using
data to drive quality improvement [1]. We hypothesize that redesign-
ing the perioperative pathway will add value through improved qual-
ity and reduced resource utilization.
Methods
Our multidisciplinary team is developing an integrated Peri-
operative Medicine care pathway at a large tertiary referral Uni-
versity hospital. Current pathways were mapped, analyzed and
redesigned with particular focus on specific factors including
defining the pathway boundaries, engaging patients and time
constraints.
Results
Current preoperative pathways were mapped and analyzed (see:
Fig 2a). Pathway redesign addressed a number of specific aims (see:
Fig. 2b): identification of the “moment of contemplation of surgery”,
early targeted preoperative information gathering through a patient-
driven online system; routine physiological assessment to stratify risk
early in the preoperative pathway (“patient staging”) by cardiopulmo-
nary exercise testing; a dedicated clinic for patients at high peri-
operative morbidity/mortality risk, collaborative decision-making and
early medical optimization; Fit4Surgery School for all patients under-
going major surgery, targeting patient education, expectation man-
agement and lifestyle optimization; standardized perioperative
management based on risk strata; postoperative care team clinical
ward reviews for “at-risk” patients; postoperative electronic data cap-
ture to monitor Enhanced Recovery targets, morbidity, and patient-
reported outcomes.Conclusion
Perioperative medicine offers a unique opportunity to add value
through improved outcomes and reduced resource utilization in pa-
tients undergoing major surgery. Extensive pathway redesign may be
needed to ensure an integrated approach, maximizing the opportun-
ities for improvements in preoperative optimization and postopera-
tive care. Moving the evaluation of risk to a position earlier in the
pre-operative pathway offers opportunities for risk mitigation, collab-
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Background/Introduction
Cardiopulmonary exercise testing (CPET) is increasingly used for pre-
operative risk assessment. Evidence to date suggests utility for pre-
dicting risk of postoperative morbidity and mortality across a
number of surgical specialties [1]. It is commonly used to triage pa-
tients to postoperative critical care [2] and to inform preoperative
risk discussions. We report its use for preoperative collaborative deci-
sion making in a large University hepatopancreatobiliary (HPB) surgi-
cal unit in which postoperative critical care admission is routine.
Methods
Patients undergoing assessment for liver resection and pancreatico-
duodenectomy in 2014 and 2015 underwent symptom limited incre-
mental exercise testing at the surgeons’ discretion. Data collected
included anaerobic threshold (AT), peak oxygen consumption
(peakVO2) and ventilatory equivalents for carbon dioxide at AT (VE/
VCO2), clinical plan made on the basis of CPET, intensive care and
hospital length of stay (LOS) in operated patients. Based on prior lit-
erature, physiological risk was reported to the clinical team as “low
risk” (AT > 10mlO2.min
-1.kg-1), “high risk” (AT 8-10mlO2.min
-1.kg-1) or
“very high risk” (AT <8mlO2.min
-1.kg-1).
Results
146 patients underwent CPET. Median (IQR) age was 69 (62–74), with
mean (SD) AT 9.6 (2.6) mlO2.min
-1.kg-1. This is lower than previously
published series of HPB patients [3] and may reflect selective referral
of patients where the surgeon has concern about baseline
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these 13 (8.9 %) had disease that was assessed as non-resectable
whereas 18 (12.3 %) had very high physiological risk (mean AT 6.5
mlO2.min
-1.kg-1; p < 0.0001 compared with operated group). Pursuing
non-surgical treatment in these patients involved collaborative deci-
sion making between patient, surgeon, anesthesiologist and oncolo-
gist. Each potential treatment was explored in terms of benefits and
risks, including the individualized risk level of postoperative morbid-
ity / mortality suggested by CPET results. Alternative treatments in-
cluded transarterial chemoembolization, chemotherapy, interval
disease surveillance and palliative care.
Furthermore, in nine “high-/very high- risk” cases undergoing surgery
(8 % of operated group), perioperative care was significantly modi-
fied based on CPET findings. This included four cases of optimization
of cardiac medication for exercise-induced ischemia / arrhythmia and
two respiratory interventions. This preoperative optimization group
proceeded to surgery in a timely fashion (median time from test to
surgery 9 days, range 1–20) and had postoperative outcomes in line
with the lower risk CPET group: critical care LOS 1 day (range 1–6
days), hospital LOS 8 days (range 2–9 days).
Conclusion
Even in centers and surgical specialties where postoperative critical
care admission is routine, preoperative CPET in a higher risk subset
of the overall patient group has utility in guiding shared decision
making. This includes consideration of non-surgical options in pa-
tients at very high risk of postoperative morbidity and mortality, and
timely optimization of cardio-respiratory limitations revealed during
CPET.
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Introduction
Perioperative care in the United States is often costly and fragmen-
ted, particularly for complex episodes of care. Our group has recently
demonstrated how care redesign built upon enhanced recovery after
surgery (ERAS) principles can decrease length of stay, postoperative
complications, and cost of care for colorectal surgery patients.[1]
However, there is little data surrounding such efforts for microvascu-
lar breast reconstruction patients.[2]
Methods
Following the same principles from earlier care redesign efforts [1],
we implemented an ERAS pathway for all microvascular breast recon-
struction patients in August 2015. After IRB approval, records were
obtained for all elective microvascular breast reconstruction proce-
dures performed for Phase 0 (2/1/2012-8/16/2015) and Phase 1 (8/
17/2015 - 1/31/2016). Patient age and BMI were obtained along with
intraoperative morphine equivalents. Case mix index and length of
stay were abstracted from hospital billing records.
Results
154 charts were reviewed; 125 in Phase 1 and 29 in Phase 2. There
were no differences in baseline characteristics between the twogroups. Median length of stay was reduced in the ERAS group (4.36
vs 3.37, p = 0.002). Intraoperative morphine equivalents were also re-
duced in the ERAS group (44.71 vs 11.90, p < 0.001). Readmission
rates were unchanged between the groups.
Conclusion
The ongoing ERAS pathway development by our Perioperative Con-
sult Service for patients undergoing microvascular breast reconstruc-
tion significantly shortened median length of stay and decreased
intraoperative opiate use while not affecting readmission rates.
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Introduction
Enhanced Recovery Pathways (ERPs) have gained favor in the United
States as effective approaches to improve the quality and value of
perioperative care. Most ERPs focus on pre-operative preparation, an-
algesia, fluid management and early mobility with a focus on improv-
ing performance on in-hospital metrics (length of stay and cost). Few
ERPs include processes related to the hospital to home transfer and
little has been reported regarding the rate and characteristic of pa-
tient readmission. We designed a study to determine the rate and
reasons for readmissions in ERP vs. non-ERP patients and to identify
areas to optimize ERP to prevent readmissions.
Methods
Patients enrolled in an ERP for colorectal surgery between February
and December 2014 (ERP) were compared to a similar cohort of pa-
tients who received surgery prior to protocol implementation (pre-
ERP). Outcomes of interest included 30-day readmission rates,
composite LOS, and readmission diagnosis.
Results
A total of 346 preERP and 330 ERP patients were included in the ana-
lysis. ERP was associated with a significant reduction in index
hospitalization LOS (5.3 vs. 7.0 days; p < 0.001) and incidence of post-
operative surgical site infection (SSI; 7.3 vs. 16.6 %; p = 0.013) com-
pared to preERP. Rate of readmission within 30 days (17.6 vs. 19.4 %;
p = 0.55) as well as mean time to readmission (9.0 vs. 8.7 days; p =
0.83) was similar between groups. As a result of similar readmission
hospitalization LOS (5.7 vs. 5.2 days; p = 0.64), the composite hospital
LOS was also similar between groups (12.0 vs. 13.5 days; p = 0.298).
The table denotes the readmission diagnoses for each group, which
a significant reduction in readmissions for SSI in the ERP group com-
pared to preERP counterparts.
Conclusion
Although ERP did not lead to a reduction in hospital readmissions,
patients received significant benefit through a reduction in index
hospitalization length of stay and rates of postoperative SSI. To im-
pact readmissions, teams should consider including care transition
process measures into ERP. Common care transition process mea-
sures aimed at reducing readmission and improving patient out-
comes such as the use of transition guides for high-risk patients,
remote vital sign and symptom monitoring, early clinical follow up
Perioperative Medicine 2016, 5(Suppl 1):21 Page 5 of 13and post-discharge pharmacist follow up have not traditionally been
part of ERP protocols. Incorporation of such measures into ERP has
the potential to reduce rates of post-operative complication and
readmissions particularly for high-risk patient populations.Readmission Diagnosis PreERP (n = 67) ERP (n = 58) P-value
SBO/ileus 13 (19.1 %) 18 (31 %) 0.133
High output stoma 6 (9.0 %) 4 (6.9 %) 0.672
All SSI 34 (50.7 %) 17 (31 %) 0.015
Superficial/Deep SSI 16 (23.9 %) 6 (10.3 %) 0.048
Organ Space SSI 18 (26.9 %) 11 (19 %) 0.297
Thromboembolic event 0 (0 %) 3 (5.2 %) 0.060
Bleeding 0 (0 %) 2 (3.4 %) 0.125
Other 14 (20.9 %) 14 (24.1 %) 0.665A9
The Manchester surgical outcomes project: prevalence of pre
operative anaemia and peri operative red cell transfusion rates
Authors: Leanne Darwin1, John Moore2
1North West Health Education England, Manchester, UK; 2Central
Manchester Foundation Trust, Manchester, UK
Correspondence: Leanne Darwin – North West Health Education
England, Manchester, UK
Perioperative Medicine 2016, 5(Suppl 1):A9
Background
Preoperative anaemia is a common problem [1]. It is independently
associated with an increased risk of 30 day morbidity and mortality
[2] and potentially treatable.
The Manchester Surgical Outcomes Project (MSOP) is a prospective
observational cohort study of patients admitted to critical care fol-
lowing elective surgery. It is a Manchester Royal Infirmary (MRI) initia-
tive to continuously collect peri operative morbidity data, enabling
targeted quality improvement work. MSOP aimed to ascertain the
prevalence of pre op anaemia, proportion of microcytosis and the
rate of post operative red cell transfusion.
Methods
Demographic data, preoperative haemoglobin concentrations, mean
corpuscular volume (MCV), and number of units of red cells trans-
fused during hospital admission were collected on patients who
underwent surgery between September 2014 and May 2015. Inclu-
sion criteria were adult patients undergoing elective non-cardiac,
non-orthopaedic surgery who were admitted to critical care following
surgery. Anaemia was defined using the World Health Organisation
criteria. Microcytosis was defined as an MCV < 80 fl.
Results
488 patients were included for analysis. 58 % (n = 282) male; 42 % (n
= 206) female. 80 % (n = 391) of operations were for cancer.
Overall 39 % (n = 191) were anaemic pre operatively. 14 % (n = 27) of
anaemics were microcytic.
The surgical specialties with highest prevalence of anaemia were
upper GI (56 %, n = 24) and colorectal (43 %, n = 23). Hepatobiliary
surgery constituted the largest surgical specialty represented (37 %,
n = 180).
The overall mean average number of units of red cells transfused
during the hospital admission was 1.47. The mean average red cell
transfusion rate increased with severity of anaemia from 1.0 unit per
non anaemic patient to 6.0 units per severely anaemic patient.
Conclusion
We found a prevalence of preoperative anaemia at the higher end of
that found in other studies [1].
The data is limited by the absence of haematinic studies. MCV is
used as a pragmatic surrogate marker for iron deficiency anaemia.
It is likely that the true prevalence of iron deficiency is greater than
14 %.Management of pre operative anaemia has been challenging at MRI
due to barriers such as the limited timeframe available for pre opera-
tive optimisation prior to cancer surgery.
We have used this data to support the development and implemen-
tation of a pre operative anaemia project in pilot specialties: colorec-
tal, hepatobiliary and upper GI surgery. We are aiming for early
identification, assessment and management of anaemia including
the use of intravenous iron when indicated.
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Background/Introduction
Gastrointestinal (GI) recovery after major abdominal surgery can be
delayed from ongoing need for narcotic analgesia thereby prolong-
ing hospitalization. Enhanced recovery after surgery (ERAS) is a multi-
modal perioperative care pathway designed to facilitate early
recovery after major surgery by maintaining preoperative body com-
position and physiological organ function and modifying the stress
response induced by surgical exposure.[1] Enhanced recovery pro-
grams (ERPs) in colorectal surgery have decreased the duration of
postoperative ileus and hospital stay while showing equivalent mor-
bidity, mortality and readmission rates in comparison to the trad-
itional standard of care.[2, 3] Laparoscopic living donor nephrectomy
has significantly transformed the outlook for individuals considering
kidney donation.[4] However, a 30 % rate of Emergency Room visits /
readmission was recorded at our center in 2014 largely from delayed
GI recovery. Thus, a pilot trial to utilize ERAS protocols in living kid-
ney donors was initiated.
Methods
This is a single-center retrospective analysis comparing the outcomes
of the first 14 live kidney donors subjected to laparoscopic nephrec-
tomy with ERAS protocol to 18 donors operated prior to ERAS with
traditional standard of care. Both groups were matched by patient
demographics. Our ERP includes reduced duration of fasting with
preoperative carbohydrate loading, intraoperative fluid restriction to
3 ml/kg/hr, target urine output of 0.5 ml/kg/hr, use of sub fascial
Exparel injection (Bupivacaine liposome suspension) and postopera-
tive narcotic free pain regimen with Acetaminophen, ketorolac,
tramadol.
Results
ERAS protocol reduced postoperative median length of stay de-
creased from 2.0 to 1.0 days (P 0.001). Overall pain scores were sig-
nificantly lower in the ERAS group (peak pain score 6.50 vs 9.00 - p
0.001, morning after surgery pain score 3.00 vs 7.00 - p 0.012) des-
pite absence of narcotics in the postoperative period. Average dur-
ation of surgery was shorter with the ERP as compared to the
standard protocol (241 vs 277 min - p 0.019). Average amount of in-
traoperative fluid used was significantly lower in the ERAS group in
comparison to standard of care protocol (2000 ml vs 3000 ml, p
0.002), without affecting the donor urine output intraoperatively or
the percent change in donor serum creatinine on postop day 1 (70
vs 77, p 1.000). Incidence of delayed graft function was similar in the
Perioperative Medicine 2016, 5(Suppl 1):21 Page 6 of 13two groups (2 vs 1, p 0.597). A trend towards lower readmission was
noted with the ERAS protocol. (2 vs 4, p 0.656). GI dysfunction was
the most common reason for readmission.
Conclusion
Application of ERAS protocol in laparoscopic living donor nephrec-
tomy was associated with reduced length of hospitalization. Im-
proved pain scores resulted from intraoperative use of sub fascial
Exparel and shorter duration of ileus. This is likely related to optimiz-
ing intraoperative fluids thus preventing excessive third spacing &
bowel edema which prolongs gut recovery. The restricted use of
intravenous fluids during donor surgery did not adversely impact re-
cipient graft function. This study suggests that ERAS has the potential
to enhance the advantages of laparoscopic surgery for live kidney
donation through optimizing donor outcomes and perioperative pa-
tient satisfaction. ERP’s can further incentivize donors for undergoing
laparoscopic live kidney donation.
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Operative Time Mean(SD) 286.28(53.89) 243.00(39.88)
Min—Max 167.00–391.00 189.00–312.00 0.0195
Median 277.00 241.00







Length of stay Mean(SD) 2.41(1.58) 1.07(0.27)
Min—Max 1.00–7.00 1.00–2.00 0.0012
Median 2.00 1.00
Readmission No 12(75.0 %) 12(85.71 %) 0.6567
Yes 4(25.0 %) 2(14.29 %)
Peak pain score Mean(SD) 8.22(1.73) 5.93(1.90)
Min—Max 4.00–10.00 3.00–9.00 0.0015
Median 9.00 6.50
Morning pain score Mean(SD) 5.61(2.99) 3.00(2.25)
Min—Max 0.00–10.00 0.00–8.00 0.0126
Median 7.00 3.00
Low pain score Mean(SD) 1.39(1.65) 0.50(0.94)




No 14(93.3 %) 12(85.71 %)
Yes 1(6.7 %) 2(14.29 %) 0.5977A11
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Introduction
Enhanced Recovery After Surgery (ERAS) pathways challenges trad-
itional surgical care. While ERAS programs are associated with im-
proved outcomes and cost, implementation and sustainability are
recognized challenges. Since 2008, the McGill University Health
Centre (MUHC) introduced ERAS elements to guide perioperative
care in 12 pathways aiming to increase patient’s participation in their
care. The purpose of this presentation is to describe the role, tasks
and responsibilities of the ERAS nurse coordinator to guide senior
management and nurses in leadership positions who wish to begin a
new program or expand an existing program. Key factors that facili-
tated the implementation and sustainability of this organizational
change at the MUHC are presented. The author will share insights
learned from her experience, raise awareness of the nurse coordina-
tor’s key role and positively recognize her institution for supporting
her role and for their outstanding collaboration. It summarizes how
the leadership style, the organizational culture and the type of
change facilitated the implementation.
Methods
Growing evidence suggests using a theoretical framework or model
to bring change in an organization increases the likelihood of suc-
cess. The theoretical Framework based on Innovation of Diffusion
Model and the Plan Do Study Act cycle guided our implementation
plan. This ensured a balance between the need to provide protocol
guidance using standard order sets and nursing plans with the need
for efficiency and ease-of-use by the clinician.
Results
Our various publications show a decrease in hospital length of stay,
without increasing complications or readmission rates. As the first
North American ERAS Society Center of Excellence, the MUHC assists
other institutions to implement the ERAS care system. The MUHC
ERAS program is listed in Accreditation Canada’s Leading Practices
Database.
Conclusion
As more and more hospitals apply lessons learned from the en-
hanced recovery experience in colorectal surgery to other surgical
procedures, there will be an increased need for a nurse coordinator
to lead this organizational change. ERAS helps to develop a culture
focused on patient recovery and actively integrate patient’s participa-
tion in care. An organization wishing to start an ERAS program
should set goals, report on the results, invest time to build the care
pathways and provide strong leadership.
A12
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Introduction
This study was conducted to assess the impact of intravenous acet-
aminophen (IV-APAP) as part of a multimodal analgesia (MMA) ap-
proach compared to IV opioid monotherapy on hospitalization costs
in patients undergoing orthopedic surgery, including total knee re-
placement, total hip replacement, or surgical repair of hip fracture
for postoperative pain management.
Methods
A retrospective analysis of Truven Health‘s MarketScan Hospital Drug
Database (HDD), was conducted comparing patients undergoing
Perioperative Medicine 2016, 5(Suppl 1):21 Page 7 of 13orthopedic surgery who received multimodal postoperative pain
management with combination IV APAP and other IV analgesics (IV-
APAP group) to those who received only IV opioids (IV opioid group)
starting on the day of surgery. Both groups could receive oral analge-
sics as part of their postoperative pain management regimen. Pa-
tients who underwent elective orthopedic surgery at 1 of 600
participating hospitals between January 1, 2011 and August 31, 2014,
were identified and separated into postoperative pain treatment
groups. Patients with evidence of substance abuse disorder and
those who used methadone or buprenorphine in addition to other
opioids were excluded. The 2 treatment groups were compared re-
garding baseline characteristics and total hospitalization costs. Differ-
ences in categorical variables were assessed using chi-square tests,
while differences in continuous variables were assessed using t-tests.
A multivariate sensitivity analysis was also conducted using inverse
probability of treatment weighting (IPTW) with propensity scores.
Results
The IV-APAP (n = 33,954) and IV opioids (n = 110,300) groups were
significantly different (but not clinically meaningful) across all base-
line characteristics including mean age (62.1 years [IV-APAP] vs.
61.4 years [IV opioids]), percent female (56.4 % vs. 55.1 %) and if the
hospital was a teaching hospital (16.6 % vs. 16.4 %); all P < 0.0001.
Mean total hospitalization costs, which included medical costs and
pharmacy costs, were statistically significantly lower for patients in
the IV-APAP group as compared to patients in the IV opioids group
($12,540 vs. $13,242; P < 0.0001; see Table 1). Medical costs (medical/
surgical supplies, laboratory testing, imaging, and other costs), drove
the difference between treatment groups, encompassing $701 of the
$702 between-group difference. Pharmacy costs were similar for the
IV-APAP group as compared to the IV opioids group. The total cost
difference remained statistically significant in the multivariate ana-
lysis, with IV-APAP utilization associated with $830 lower
hospitalization costs compared to IV opioids (P < 0.0001).
Conclusion
Patients undergoing orthopedic surgery who received IV-APAP as
part of MMA for postoperative pain had lower total costs than pa-
tients in the IV opioid group. This difference was mainly driven by
medical costs. There was no difference observed in pharmacy costs
between treatment groups.Table 1 (abstract A12). Total costs for patients undergoing orthopedic
surgery
IV-APAP (n = 33,954) IV Opioids (n = 110,300) P Value
Mean SD Mean SD
Total costs $12,540 $9,564 $13,242 $35,825 <0.0001
Medical costsa $12,053 $9,377 $12,754 $34,870 <0.0001
Medical/surgical supplies $2,795 $1,870 $2,889 $5,717 <0.0001
Lab $197 $301 $219 $1,019 <0.0001
Imaging $91 $129 $105 $238 <0.0001
Otherb $8,970 $7,922 $9,541 $30,735 <0.0001
Pharmacy $486 $488 $488 $1,120 0.6786
aMedical costs = medical/surgical supplies costs + lab costs + imaging
costs + other costs
bExamples of costs included in “Other“are room and board, EKGs, oxygen,
and ventilation Fig. 3 (abstract A13). Bar chart to show distribution of length of stay
for all enhanced recovery colorectal surgery patients (May-July 2015)A13
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There is compelling evidence that Enhanced Recovery Pathways
(ERP’s) reduce length of hospital stay, complications and mortal-
ity. Their economic benefit is similarly impressive, saving hos-
pital bed days and costs. Implementing and maintaining good
levels of compliance with the multi-facetted pathway is challen-
ging, and deviation from, and lack of adherence to a pathway
translates to a dilution of benefits. Our organisation wanted to
develop a tool to improve compliance with ERP’s, examine out-
comes with greater granularity and place the patient at the very
centre of their care.
Methods
We worked with a computer scientist to produce a bespoke “app”
for our enhanced recovery colorectal patients. Checklists were em-
bedded within the app architecture corresponding to nineteen
recognised elements of an enhanced recovery pathway. In addition,
the app included “goal-based” targets for patients to aid their recov-
ery, standardised and validated outcome metrics, patient diaries and
satisfaction and experience interfaces. The work represented service
evaluation and did not require ethics approval. An enhanced recov-
ery specialist nurse collected data for all ER colorectal surgical pa-
tients from May - July 2015.
Results
Data was collected for 48 patients. All patients used the patient-
facing side of the app. Mean length of stay for all enhanced recovery
colorectal surgery was 7.4 days (see Fig. 3 below). Analysis of data
from the same time period in the previous year for colectomies and
excision of rectum procedures demonstrated a reduced mean length
of stay of 4.4 days in the intervention period (11.8 days versus
7.4 days). Overall compliance with the enhanced recovery pathway
was 93 %. 92 % drinking, eating and mobilising on day zero, and
98 % on day 1 postoperatively.
Mean scores for satisfaction with anaesthesia and surgery were 4.2
and 4.2 respectively, out of a maximum score of 5. 93 % of patients
would recommend the institution to friends and family, based on the
treatment they received.
Conclusion
Based on our experience to date with an app that supports compli-
ance with ERP’s, engages patients, and tracks and benchmark out-
comes, we suggest this technology provides a high-value, low-cost
tool to drive quality improvement. Further work is needed to evalu-
ate the role of App’s in improving outcomes and patient experience
in healthcare.A14
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Enhanced Recovery After Surgery (ERAS) pathways are evidence
based, multidisciplinary perioperative bundles of interventions that
have been shown to reduce length of stay, complications and costs
and improve the patient experience following surgery. They are
widely adopted in Europe and Canada and are increasingly being im-
plemented in the United States. Currently, there are no published
programs for educating medical students about ERAS programs. In
the basic surgery clerkship at our institution, there were limited op-
portunities for learning about ERAS programs because of an em-
phasis on spending time in the operating room. Additionally, few
students had the opportunity to rotate on service lines that featured
an ERAS program. A survey of medical students done in the United
Kingdom, where ERAS is widely implemented, found that only 14 %
of students had heard of ERAS [1]. We sought create a clinical rota-
tion that gave students the opportunity to engage with the many
facets of our ERAS program at the three sites within the Johns Hop-
kins Medicine system.
Methods
We developed a four-week curriculum that had three core objectives.
First, the student was to engage with the wide variety of allied health
providers that participate in the ERAS program. The goal was to gain
a 360 degree appreciation for the patient’s surgical journey; from the
initial office visit, to follow up home care nursing. Second, the stu-
dent was to become familiar with the evidence base behind the
ERAS program. The student was expected to prepare weekly presen-
tation on one aspect of the ERAS pathway. Last, the student was ex-
pected to engage in the clinical research associated with the ERAS
pathway. The pilot rotation was set for February 2016.
Results
Over the course of the month long curriculum, the student was able
to able to interact with a wide range of allied health providers, in-
cluding; surgeons, anesthesiologists, physician assistants, CRNAs,
nursing staff on the surgical floors, as well as home visits with the
home care nursing team. This allowed for a more complete view of
the surgical journey and emphasized the wide range of providers
that need to collaborate for excellent perioperative care to be suc-
cessful. The student was able to rotate a three different sites, Johns
Hopkins Hospital, Bayview Medical Center, and Sibley Memorial Hos-
pital, and appreciate how the ERAS programs were implemented in
unique ways at each site. Having a student rotate through each of
the site improved collaboration between the ERAS programs at dif-
ferent sites. The weekly PowerPoint presentations were archived and
kept for future students to reference as they go through the rotation.
Conclusion
This initial trial of an ERAS elective for Medical Students provided a
global view of the surgical journey and imbued a greater appreci-
ation for how allied medical professionals come together to provide
excellent evidence based perioperative care. We look forward to of-
fering this elective to future students as well as preparing a didactic
session to be integrated into the core surgery clerkship.
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Background
Breast reconstruction continues to be important for many women
with breast cancer. Following a mastectomy, the breast may bereconstructed with either implants or the patient’s own tissue. The
benefit of breast reconstruction with tissue is the more natural feel
and long term durability in comparison to implants. The downside of
a tissue reconstruction is the donor site scar and perceived complex-
ity and pain associated with this approach. Through refinements in
technique, breast reconstruction with abdominal tissue has become
more streamlined and less invasive. As the techniques have evolved
so has the management of the patient in the perioperative period.
Enhanced Recovery After Surgery (ERAS) initiatives have been imple-
mented in many hospitals with the aim to improve post-operative
physiologic function and recovery. In this study, we sought to com-
pare the outcomes of patients undergoing abdominal based free flap
breast reconstruction before and after implementation of the ERAS
protocol.
Methods
This is an IRB approved retrospective study which involves analysis
of data extracted from chart review. Evaluable subjects were defined
as those who have undergone abdominal free flap breast reconstruc-
tion at Duke University Hospital, identified using the CPT code
19364. Patients with pre-existing psychiatric and chronic pain condi-
tions were excluded. The ERAS protocol was implemented in May of
2015. For this study, data was collected from 10/1/2014 through 1/1/
2016 in order to include patients before and after implementation of
ERAS protocol. Patient demographics, perioperative surgical and
anesthesia data, need for analgesics, and complications were col-
lected and summarized. Statistics were done with JMP and Microsoft
excel 2013.
Results
There were 17 patients in the control and 21 patients in the ERAS
group. Both groups had similar age, race and BMI. The patients in
the ERAS group had a significantly reduced length of stay (LOS) (3.8
v. 4.76 days, p = 0.0003, t-test). There was no significant difference in
24 hr morphine equivalent dosage (MED) (34.17 vs. 22.2 mg, p = 0.26,
t-test). However, intravenous (IV) pain medication usage was reduced
in ERAS patients (14/21 v. 17/17 patients, p = 0.0049, t-test) and pa-
tients had earlier return of bowel function (POD 2 v. 3.5, p = 0.002, t-
test). There was no significant difference in the rate of flap loss be-
tween groups (6.45 % ERAS v. 3.57 % control, p = 0.617, t-test).
Conclusion
Implementation of an ERAS protocol for abdominal free flap breast
reconstruction at a tertiary medical center was associated with a sig-
nificantly reduced LOS, decreased IV narcotic pain medication usage
and earlier return of bowel function. This is consistent with results
seen in colorectal surgery and suggests that this program could be
instituted nationwide for standardization of breast reconstruction
with improved outcomes.
Table 2 (abstract A16). Patient Outcomes Pre- and Post-ERAS
Implementation
Pre-ERAS Post-ERAS P Values
May 2011 – Sept. 2014 Oct. 2014 –
Nov. 2015
n = 90 n = 91











10 % ↓1.1 % p < 0.05
Transfusion (72 hr
of OR start time)
43.3 % ↓29.7 % p = 0.0695
Readmissions
Within 30 Days
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Background
Despite improvements in surgical techniques and perioperative
care protocols, radical cystectomy (RC) is still associated with
higher morbidity than other urological procedures. In our hos-
pital, RC had accounted for 38.2 % of postoperative complica-
tions but only 13.6 % of the total urological case volume as
demonstrated in the risk-adjusted reports (07/2011-06/2014)
from the American College of Surgeons National Surgical Qual-
ity Improvement Program (ACS NSQIP). Morbidity impacts pa-
tient’s safety and experience, increases hospital length of stay
and health care costs.
The multimodal evidence-based perioperative care pathway En-
hanced Recovery After Surgery (ERAS) offers opportunity to reduce
complications after major surgery, which has been validated in the
elective colorectal cases in our hospital.
Methods
A multidisciplinary team was formed in April 2014. A project
charter and an implementation plan were initiated. ERAS docu-
ments such as order sets, patient education booklet and clinical
pathway were developed. Comprehensive and ongoing educa-
tion on ERAS principles and our local experience were shared
with the surgical staff. In October 2014, we implemented our
ERAS protocol to all Urology patients undergoing elective rad-
ical cystectomy surgery. Real time auditing of compliance with
the 21 ERAS components and measuring of post-operative com-
plications, hospital length of stay and readmission as defined
by the American College of Surgeons National Surgical Quality
Improvement Program (ACS NSQIP) were started immediately
post ERAS implementation. Results for pre- and post-ERAS co-
horts were compared, using Fisher’s exact test. The goal was to
decrease the overall morbidity for target patient population by
50 % by September 2015.
Results
For the first 13 months post implementation, 91 consecutive
radical cystectomy patients had been enrolled in the ERAS pro-
gram. Patient demographics and co-morbidity counts were simi-
lar in both cohorts. Process measures showed that the pre-
operative and intra-operative components had met and sus-
tained our goal of a minimum of 80 % compliance within first
month post implementation. Post-operative components have
been the slowest to change, but they are trending towards our
goal. The rates of post-operative overall morbidity fell from
31.3 % to 18.7 % (p = 0.059). UTI declined from 10 % to 1.1 %
(p < 0.05), which was statistically significantly lower post imple-
mentation as seen in Table 2.
Conclusion
Teamwork and communications of a multidisciplinary team are
crucial to a culture of patient safety. Use of real-time auditing
and the Plan-Do-Study-Act (PDSA) cycles enhance our rate of
improvement. Aggregation of marginal gains can result in dra-
matic improvements in patient outcomes, which has proven in
elective radical cystectomy cases after ERAS implementation in
our hospital.A17
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Background
Patient engagement with enhanced recovery pathways (ERP’s)
forms up to thirty percent of a pathway’s portfolio of compli-
ance elements. This includes consumption of preoperative
carbohydrate drinks, early mobilisation and resumption of oral
intake. In addition to these explicit elements; by making trans-
parent the goals of a pathway, the patient may implicitly im-
prove their pathway compliance, by challenging and engaging
with clinicians on their progress and attainment of recovery
milestones.
Methods
We used an app to track compliance with elements of enhanced re-
covery for colorectal surgery. The app contained both patient-facing
and clinician-facing domains. From May - July 2015, all patients en-
rolled on a colorectal ERP in our institution (n = 48) used the app. As
they moved through the pathway, the app provided prompts and
opportunities to remind and engage with them on the anticipated
goals of recovery, explicitly making clear expectations such as post-
operative exercise. (See Fig. 4)
Results
100 % (n = 48) used the app. Compliance with patient-centred ele-
ments of the pathway was 93 % (i.e. for preoperative CHO drinks,
mobilisation and resumption of oral intake). This is compared to
pathway compliance of 19 % for preoperative CHO drinks, prior to
the introduction of the app.
Conclusion
Compliance with the pathway since the introduction of the app
has improved to 93 %. By putting the patient at the centre of
their care and making transparent the goals of recovery,
compliance and outcomes are improved. We firmly believe that
patients represent a powerful driver for improved delivery of
healthcare. More efforts should be made to make patient
Perioperative Medicine 2016, 5(Suppl 1):21 Page 10 of 13information and goals of recovery readily available to patients.
The architecture of apps provides a useful platform on which to
pursue this venture.Fig. 4 (abstract A17). Typical screenshot of patient-facing interaction
with colorectal ERPA18
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Introduction
Perioperative care in the United States is often costly and fragmen-
ted. A number of studies have demonstrated that enhanced recovery
after surgery (ERAS) programs reduce morbidity, hospital costs, and
length of hospital stay [1], however there have been no documented
ERAS protocols for living donor nephrectomy patients assessing ef-
fectiveness in this patient population. The concept of the Periopera-
tive Surgical Home (PSH) advances upon ERAS by placing these
multi-component care pathways into a system of care that spans the
period from decision to discharge. In partnership with kidney trans-
plant surgeons at our institution, we developed and incorporated an
ERAS pathway for living donor nephrectomies through our existing
PSH known as our Perioperative Consult Service (PCS).
Methods
After IRB approval, records were obtained for all living donor neph-
rectomies (2/07/2013 - 1/28/2016). All patients undergoing a living
donor nephrectomy performed by a kidney transplant surgeon as
identified by their primary procedural surgical code were included.
Post implementation of our ERAS pathway, all living donor nephrec-
tomy patients were included unless had allergy to medication in
protocol, contraindication to regional anesthesia, or patient refusal.
Patient ASA classification, gender and BMI were obtained, along with
morphine equivalents. Length of stay was abstracted from hospital
billing records.
Results
142 charts were reviewed; 113 were pre implementation of our
protocol (2/07/2013 – 7/27/2015) and 29 were post implementation
(7/28/2015 – 1/28/20016). There was no difference in ASA classifica-
tion or gender, BMI, or preoperative morphine equivalents between
the two groups. All procedures were performed laparoscopically. In-
traoperative and Post Anesthesia Care Unit morphine equivalents
were significantly reduced between pre and post implementation of
protocol (39.21 vs 4.38, P <0.001 and 7.24 vs 2.54, p < 0.001 respect-
ively). Mean and median length of stay was decreased between pre
and post implementation phases: 2.84 vs 2.27, p < 0.001 and 2.48 vs
2.34, respectively. Prior to implementation, only 55 % of patientswere discharged prior to POD3, whereas after implementation, 93 %
were discharged prior to POD (P < 0.001), with some patients going
home on POD1. Readmission events within 30 days, although higher
in the post implementation group, were extremely low for both
groups: 0/113 pre implementation vs 2/29 post implementation (one
for nausea and one for abdominal pain) and emergency department
visit events were 1/113 pre implementation (fever) vs 2/29 post im-
plementation (one for nausea and one for chest pain). There were no
rapid responses or postoperative ICU admissions in either group.
Conclusion
The living donor nephrectomy ERAS pathway development and im-
plementation by our PCS significantly shortened median length of
stay and decreased perioperative opiate use in living donor nephrec-
tomy surgery patients. Of note, if we are able to sustain these
changes, we will be able to liberate approximately 40 bed-days per
year even from this lower volume service. Future directions will in-
volve applying ERAS principles to kidney transplant recipients.
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Background
The practicing general surgeons at this hospital had length of stay
greater than NSQIP averages for DRGs 329–331. This varieance was
the primary motivation for an enhanced recovery (ER) initiative. Eight
general surgeons, practicing in three separate practice groups, were
introduced to the ER concepts with the desire for the entire general
surgery team to adopt and implement the designed pathway. Ini-
tially, only one surgeon became an early adopter. However, after pre-
liminary results were shared with the other surgeons, two additional
surgeons became early adopters as well. The results of the early
adopting surgeons demonstrated consistency with previously pub-
lished positive results from ER. All surgeons fully adopted the en-
hanced recovery pathway into their practice within three months
maintaining consistent results.
Methods
The anesthesia team modeled the ER pathway after accepted and
published ER guidelines [1]. The pathway was designed over three
months and initiated in January 2015. Individual surgeons were pre-
sented with the evidence, their LOS data for colorectal patients and
predetermined order sets to manage the ER patients. Participation
was determined by their compliance with the pathway for the non-
emergent colorectal surgical patients. The authors provided ER edu-
cation for surgeons, anesthesia, nursing (all phases of care), man-
agers, administration and other adjunct facility departments. The
authors closely followed the ER patients during the earlier phases of
implementation to ensure compliance. Slight modifications to the
protocol, using feedback from all practitioners, occurred in the early
stages of implementation. The continual process of audit and refine-
ment ensure compliance and any needed improvements within the
pathway.
Results
Adoption of an ER program by the institution and all of the general
surgeons was realized and accepted within the first several months
of implementation. Within the first nine months, the ER program had
a greater than 50 % reduction in LOS and a variable direct cost re-
duction of $4357 per case (Fig. 5). In addition, the reduction in other
cost buckets resulted in substantial savings for the hospital (Fig. 6).
Conclusion
The general surgeons adopted the ER program into their practice
during 2015 and are now active, enthusiastic participants within this
initiative. Initially, several of the surgeons disagreed with the well-
established ER principles, but after use of the pathway by competing
Perioperative Medicine 2016, 5(Suppl 1):21 Page 11 of 13practitioners and the revelation of the results, adoption was univer-
sal. The use of evidence based practice information presented by a
team of dedicated professionals can achieve rapid positive results in
cost savings, reduced length of stay and broad based surgical
adoption.
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Purpose: The purpose of this project is to implement an Enhanced
Recovery After Surgery (ERAS) clinic at Beaumont Health System-Troy
campus for patients undergoing elective colorectal surgery.
Introduction
Enhanced Recovery After Surgery (ERAS) is an innovative method of
patient care management designed to accelerate patient recovery
following surgery and decrease post-operative complications. ERAS
uses a multi-disciplinary approach to surgical care designed to im-
prove patient readiness, enhance patient recovery and increase patientsatisfaction throughout the entire surgical experience by allowing the
patient to actively participate in their own preparation and recovery pe-
riods. By utilizing a collection of ERAS evidence-based strategies, we can
successfully contribute to our patient’s recovery without compromising
their safety. Currently there is no standardized means of managing ex-
pectations of patients undergoing complex surgical procedures. Efforts
in the past have failed due to overly complex and often contradictory
educational efforts, and have led to patient confusion, dissatisfaction,
and poor compliance. Using established standards for healthcare literacy
as well as evidence based perioperative preparatory instructions, we
seek to properly prepare our patients for colorectal surgery. We antici-
pate that this standardized and evidence based approach will improve
satisfaction, reduce outcome variability, and shorten length of stay.
Method
To implement this program, a multidisciplinary team of experts was
assembled to drive this project forward. Team members meet
monthly and include: surgeons, anesthesiologists, nurse educator,
quality nursing, floor nursing, pharmacy, librarian, CRNAs, administra-
tive managers, and a project manager. Our comprehensive ERAS care
pathway includes many of the established ERAS protocols including:
nutrition optimization, strength and conditioning, appropriate use of
pre-medication, bowel preparation and optimization, goal directed
fluid therapy, anesthetic optimization, multimodal analgesia, gly-
cemic control, nausea and vomiting control, early feeding and bowel
stimulation, early mobilization and conditioning, multimodal anal-
gesia, glycemic control, and education and expectation management
After 1 year of the Enhanced Recovery Program we decided to open
multi-disciplinary pre-operative clinic for surgical patients. The clinic
is called the STTAR clinic which is an acronym for Surgical Testing
and Teaching for an Accelerated Recovery. It serves as a “1 stop
shop” for patients and all pre-operative activities are able to get ac-
complished during this single clinic visit. This serves as a tremendous
satisfier for the patient and helps to eliminate the last minute scram-
ble that often happens in the pre-operative unit on the day of sur-
gery. A pre-operative patient clinic visit is multi-disciplinary in nature
and includes: history and physical from a PA, consult from an
anesthesiologist, drawing of necessary labs by RN, EKG and other
diagnostics, dietary consult as needed, a goody bag with nutritional
drinks, incentive spirometer, pedometer and patient educational
booklet and visit from the ostomy nurse as needed.
Results
Based on data examining our first 150 ERAS cases in the clinic since
July 2015, we have seen a reduction in length of stay from 5.05 days
to 4.30 days with a decrease in direct cost from $8,171 to $7,245. We
have also seen a reduction in surgical site infections and a reduction
in readmissions. We have received very positive feedback from pa-
tients based on patient surveys. We anticipate seeing similar results
as the project expands.
Future Plans
Our STTAR clinic continues to grow with not only colorectal surgery
but we have expanded to Urology and have included cystectomies.
Our future plan is to expand to other disciplines including orthope-
dics and spine surgery.
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Introduction and objectives
Gastrointestinal (GI) complications are common after radical cystec-
tomy (RC) and urinary diversion (UD). Enhanced recovery after sur-
gery (ERAS) protocols aim to optimize GI function, and predicated on
Perioperative Medicine 2016, 5(Suppl 1):21 Page 12 of 13avoiding bowel preparation and nasogastric tubes, early feeding,
focus on nonnarcotic pain management and the use of cholinergic
and mu-opioid antagonists. We evaluated whether our institutional
ERAS protocol was associated with changes in GI function and com-
plication rates in the first 30 days after RC and compared them to
our previous traditional method of postoperative care.
Methods
Using our bladder cancer IRB approved database, we identified 377
consecutive patients who underwent open RC and UD using our
ERAS protocol from 5/2012 to 12/2015. Also, we identified a control
group who were treated with traditional (non-ERAS) post-operative
care using our institutional bladder cancer database (2003 to 2012).
We compared bowel activity in the postoperative period as well as
GI complications for the first 30 days. Postoperative ileus (POI) was
defined as oral intake intolerance that persisted beyond 5 days after
surgery or by nausea and emesis with accompanied abdominal dis-
tention requiring GI rest, or a nasogatric tube at any time postopera-
tively. Complications were recorded based on Clavian-Dindo system.
Results
A total of 145 patients on ERAS arm and 144 matched controls were
included in the study. Median time from surgery to first bowel move-
ment was 2 days in the ERAS arm and 5 days in the control group (p
= 0.003). GI complications within 30 days occurred in 19 (13 %) pa-
tients with the ERAS protocol and 40 (27 %) of controls (p < 0.001);
the most common GI complication was postoperative ileus (POI)/par-
tial small bowel obstruction (pSBO) in both groups (7 % vs. 23 %; p
< 0.001) (Table 3). Nasogastric or gastric tube placement was re-
quired in 11 patients (7 %) in the ERAS arm compared with 25 pa-
tients (17 %) controls (p = 0.01), while Total parenteral nutrition was
required in one (0.6 %) patient in the ERAS cohort and 8 (6 %) con-
trols (p = 0.02). Median length of hospital stay (LOS) was significantly
shorter in ERAS cohort compared to controls [4 (range, 3–16) d vs. 9
(range, 5 – 23) d; p < 0.001].
Conclusions
Our institutional ERAS protocol for RC was associated with signifi-
cantly shorter time to bowel function recovery, fewer GI complica-
tions, and a shorter LOS. This protocol should be considered to
reduce GI morbidity associated with open RC.
Keywords: bladder cancer, cystectomy, enhanced recovery, GI
complicationsTable 3 (abstract A21). GI-related complications in patients on ERAS







30-day GI complication rate (%) 19 (13) 40 (27) 0.003
Ileus/pSBO (%) 10 (7) 34 (23) <0.001
Intractable nausea/vomiting (%) 4 (3) 3 (2) 0.5
Need for NG/G-tube (%) 11 (7) 25 (17) 0.012
Need for TPN (%) 1 (<1) 8 (6 %) 0.02
C. Diff diarrhea (%) 3 (2) 1 (<1) 0.3
30-d readmission rate due to GI
complication (%)
2 (10) 2 (5) 0.1
BG BEFORE DMP BG AFTER DMP
<80 80–200 >200 <80 80–200 >200
Preoperative 0 10 3 4 30 12
Recovery Room 1 10 2 5 40 1
POD#0 4 PM 0 8 5 1 29 16
POD#0 9 PM 0 9 4 0 32 14
POD#1 7 AM 1 10 1 0 37 9
POD#1 11 AM 0 4 8 0 27 17
POD#1 4 PM 0 5 6 0 35 9
POD#1 9 PM 0 5 6 0 27 18A22
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Background
Carbohydrate loading prior to surgical procedures has been proven to
decrease peri-operative insulin resistance leading to decreased surgicalcomplication rates. Applying this process to patients with diabetes has
been questioned due to elevated preoperative blood glucose levels
with standard diabetic medication management. It is postulated that
maintaining diabetic patients on their standard regimen of
hypoglycemic medications will lead to improved perioperative blood
glucose (BG) levels. We have implemented a diabetic medication proto-
col (DMP) for Type I/II diabetics where patients undergo carbohydrate
loading and continue their standard hypoglycemic medication regimen
through the morning of surgery.
Methods
We initiated an Enhanced Recovery after Surgery (ERAS) protocol in
October 2014 where all patients undergoing total joint replacement
(TJR) received carbohydrate loading over 12 hours prior to the start
of surgery. The patients were provided with 3 bottles of a maltodex-
tran based carbohydrate drink to consume over the 12 hours prior to
surgery with the last drink taken 3 hours prior to surgical start time.
Diabetics were asked to hold any oral hypoglycemic medications and
take half their usual insulin dose the morning of surgery. On August
1, 2015 we implemented a DMP where carbohydrate loaded dia-
betics would continue, without modification, their diabetic medica-
tions until arrival at the hospital the day of surgery. We performed a
retrospective review of 57 consecutive diabetic TJR patients from Au-
gust 1 to December 31, 2015 compared with 25 consecutive diabetic
TJR patients prior to implementing the DMP.
Results
A total of 82 diabetic patients undergoing TJR were reviewed. 25 patients
prior to implementation and 57 patients after implementation were
reviewed. 12 patients prior to implementation and 11 patients after im-
plementation were excluded due to failure to comply appropriately with
medication and or carbohydrate instructions Data was extracted on pre-
operative, intraoperative, recovery room and postoperative BG levels.
Conclusions
We have been able to show that diabetic patients may safely receive
carbohydrate loading prior to TJR. Diabetic patients undergoing carbo-
hydrate loading prior to surgery are able to safely continue their dia-
betes medications prior to surgery without a significantly higher
incidence of perioperative hypoglycemia. The DMP did not lead to a
decrease in the number of patients presenting with hyperglycemia
prior to surgery though BG levels were significantly improved on
POD#1 at 4 PM. The overall number of complications was very low in
both groups, therefore the impact of this protocol on surgical out-
comes has yet to be determined. This documents the safety of carbo-
hydrate loading diabetic patients prior to surgery as well as continuing
diabetic medications until surgery. This practice should be evaluated
further to determine the impact of this protocol on surgical outcomes.A23
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Major orthopedic surgery is associated with an anticipated level of
high blood volume loss.[1,2] Pre-operative anemia is an independent
prognostic factor of increased mortality and morbidity following
orthopedic surgery.[1,3] It has been shown that approximately 40 %
of patients evaluated prior to elective orthopedic surgeries are
anemic (women Hb <12 g/dl, men Hb < 13 g/dl).[1] Pre-operative
anemia is a major predictor of allogeneic blood transfusion (ABT).[2,3]
ABT during the perioperative period is known to be associated with in-
creased rate of infections, transfusion reactions, perioperative mortality
and increased length of stay.[1,2,3] Our effort aimed at reducing the in-
cidence of blood transfusions during elective joint arthroplasty.
We instituted a Patient blood management (PBM) program as a com-
ponent of our Perioperative Surgical Home with the goal of improv-
ing patient outcomes and reducing the incidence of perioperative
anemia in joint arthroplasty patients. The goals of our PBM program
are to (1) Identify and treat pre-operative anemia, (2) Reduce autolo-
gous blood transfusions, (3) Reduce blood loss during surgery, (4) Re-
duce allogeneic blood transfusions, (5) Increase tolerance to anemia
and adaptation of transfusion triggers.
Methods
Preoperative, intraoperative and postoperative PBM protocols were
implemented for all patients undergoing elective knee and hip
arthroplasty. Preoperatively, patients were seen approximately
30 days prior to surgery for clinical evaluation and assessment, which
comprised of screening for bleeding and coagulation risk as well as
anemia. Patients were treated with one or more of the following: IV
iron, vitamin supplementation or erythropoietin stimulating agents.
Autologous blood donation was eliminated. Intraoperatively, the use
of cell savage, hemostatic agents and antifibrinolytics was instituted.
Post operatively, post-surgical anemia was assessed and treated withIV iron. Blood products ordered for joint arthroplasty patients
required approval from anesthesia prior to transfusion. Transfusion
triggers dropped to 7 g/dl in non-cardiac patients and at 8 g/dl in
cardiac patients.
Results
Since implementing the PBM program, blood utilization has de-
creased drastically. There has also been a corresponding reduction in
length of stay. At the initiation of the program in 2013, the rate of
transfusion in total knee arthroplasty was 16.50 %. There has since
been a significant decrease to 8.22 % in 2014 and 2.87 % in 2015. In
total hip arthroplasty, the average rate of transfusion was 24.44 % in
2013, with a decrease to 13.03 % in 2014 and 10.64 % in 2015. In
2013, the average length of stay was 3.20 and 3.48 for total knee
and hip arthroplasty patients with a drop to 2.86 and 3.05 respect-
ively in 2015.
Conclusion
Implementation of a patient blood management program is an ef-
fective way to treat preoperative anemia, reduce allogeneic blood
transfusions and improve patient outcomes and risk, while reducing
length of stay and reducing cost.
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